PEPTIASE

This brand name is authorized in Nigeria.

Active ingredients

The drug PEPTIASE contains one active pharmaceutical ingredient (API):

`1`	Serrapeptase UNII `NL053ABE4J` - SERRAPEPTASE
	Serrapeptase suppresses fibrinolytic activity and increased vascular permeability, suppresses edema of inflammation, strongly hydrolyzes bradykinin and cleaves fibrin and fibrinogen without affecting proteins.
	Read more about Serrapeptase

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-0515	Tablet	Peptiase Tablet TAB 10 mg 10 x 10's	Tablet	28/10/2021

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-0515

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.